PYCR2 Mutation Causing Hypomyelination and Microcephaly in an Indian Child
Preeti Srivastava1, Asit Kumar Mishra1, Nilanjan Sarkar2
1Pediatrics, Tata Main Hospital, Jamshedpur, IND.
Abstract:
Hypomyelinating leukodystrophy (HLD) represents a group of clinically overlapping but genetically heterogeneous diseases. This group of disorders has the improper formation of myelin sheaths in the central nervous system (CNS), resulting in abnormal white matter, with characteristic MRI findings and clinical presentations of mostly motor dysfunction with variable cognitive and language impairment. We report a case of a three-year-old boy with global developmental delay, dysmorphic facies, motor signs, progressive microcephaly, and failure to thrive. The child was born of a non-consanguineous marriage. All basic investigations and metabolic tests were normal. Magnetic resonance imaging (MRI) of the brain showed hypomyelination of the deep and subcortical white matter, appearing as hyperintense T2 and isointense T1-weighted images, cerebral atrophy with the thinning of the corpus callosum, with normal cerebellum, brainstem, and deep grey nuclei. Further genetic testing in the form of clinical exome sequencing revealed compound heterozygous mutation of the PYCR2 gene and matching the clinical phenotype with the genotype. Therefore, a final diagnosis of hypomyelinating leukodystrophy-10 was made. There is a wide range of aetiologies for debilitating neurologic disorders, which have common and overlapping clinical presentations. Advances in the field of genetics, growing awareness, and availability of genetic tests help in a better workup of complex neurological cases. A precise diagnosis is useful in outlining the course, treatment (if available), and prognosis of the disease to parents and plays a vital role in planning future pregnancies.
Insights
Hypomyelinating leukodystrophy (HLD) is a group of genetic disorders affecting myelin formation in the central nervous system. This case highlights a PYCR2 gene mutation causing HLD-10 in a child with developmental delay and microcephaly.
Area of Science:
- Neurology
- Genetics
- Pediatrics
Background:
- Hypomyelinating leukodystrophy (HLD) comprises genetically diverse disorders characterized by impaired myelin sheath formation in the central nervous system (CNS).
- Clinical presentations often include motor dysfunction, cognitive impairment, and specific MRI findings indicating white matter abnormalities.
Observation:
- A three-year-old boy presented with global developmental delay, dysmorphic features, motor signs, progressive microcephaly, and failure to thrive.
- Initial investigations and metabolic tests were unremarkable.
- Brain MRI revealed hypomyelination, cerebral atrophy, and corpus callosum thinning, with normal cerebellum, brainstem, and deep grey nuclei.
Findings:
- Clinical exome sequencing identified compound heterozygous mutations in the PYCR2 gene.
- The identified genotype correlated with the patient's clinical phenotype, leading to a diagnosis of hypomyelinating leukodystrophy-10 (HLD-10).
Implications:
- Genetic testing is crucial for diagnosing complex neurological disorders with overlapping symptoms.
- Accurate diagnosis of HLD-10 aids in predicting disease course, potential treatments, and prognosis.
- Understanding the genetic basis of HLD is vital for genetic counseling and family planning.


